Advances in Pharmacology, Volume 91, the latest release in this well-received series, presents the latest information in the field, with this update including chapters on Modulation of inflammation and immune response by the stress-activated transcription factor Nrf2, Therapeutic modulation of macrophage phenotype to treat acute and chronic liver diseases, Immodulation by cannabinoids, The use of nanomaterials to target immunity, Next generation in cancer immunotherapy, checkpoint inhibitors, Vaccines as a therapy for food allergy, Role of inflammation/immune system in depression, Therapeutic targeting of tumor-associated macrophages, Mast cells, and more.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Contributors - p. iii 6. Preface - p. xi 7. Chapter One: Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application - p. 1 8. Chapter Two: The role of Nrf2 in autoimmunity and infectious disease: Therapeutic possibilities - p. 79 9. Chapter Three: Review of immune checkpoint inhibitors in immuno-oncology - p. 117 10. Chapter Four: Potential therapeutic uses of rexinoids - p. 141 11. Chapter Five: Therapeutic targeting of tumor-associated macrophages - p. 193 12. Chapter Six: Modulation of macrophage phenotype to treat liver fibrosis—Current approaches and future possibilities - p. 213 13. Chapter Seven: Vaccines as therapies for food allergies - p. 235 14. Chapter Eight: Neuroimmunology of depression - p. 259 15. Chapter Nine: Nanomaterials to target immunity - p. 293
Advances in Pharmacology, Volume 91, the latest release in this well-received series, presents the latest information in the field, with this update including chapters on Modulation of inflammation and immune response by the stress-activated transcription factor Nrf2, Therapeutic modulation of macrophage phenotype to treat acute and chronic liver diseases, Immodulation by cannabinoids, The use of nanomaterials to target immunity, Next generation in cancer immunotherapy, checkpoint inhibitors, Vaccines as a therapy for food allergy, Role of inflammation/immune system in depression, Therapeutic targeting of tumor-associated macrophages, Mast cells, and more.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Contributors - p. iii 6. Preface - p. xi 7. Chapter One: Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application - p. 1 8. Chapter Two: The role of Nrf2 in autoimmunity and infectious disease: Therapeutic possibilities - p. 79 9. Chapter Three: Review of immune checkpoint inhibitors in immuno-oncology - p. 117 10. Chapter Four: Potential therapeutic uses of rexinoids - p. 141 11. Chapter Five: Therapeutic targeting of tumor-associated macrophages - p. 193 12. Chapter Six: Modulation of macrophage phenotype to treat liver fibrosis—Current approaches and future possibilities - p. 213 13. Chapter Seven: Vaccines as therapies for food allergies - p. 235 14. Chapter Eight: Neuroimmunology of depression - p. 259 15. Chapter Nine: Nanomaterials to target immunity - p. 293
